Estados Unidos · Plataformas y datos · Finviz

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Publicado por Finviz · Estados Unidos hace 3 d

AUSTIN, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE)-- FocalTherics (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that it will release its…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

También te puede interesar

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Oppenheimer reiterates Amgen stock rating on cancer drug data

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Roche lung cancer drug extends survival by nearly six months in late-stage trial

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Compartir

También te puede interesar

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Oppenheimer reiterates Amgen stock rating on cancer drug data

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Roche lung cancer drug extends survival by nearly six months in late-stage trial

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120